47.51
Bio Techne Corp (TECH) 最新ニュース
Former Novartis Deal Chief Who Led 50+ Strategic Transactions Joins OmniAb Board - Stock Titan
Leerink Partners Adjusts Price Target on Bio-Techne to $80 From $95, Keeps Outperform Rating - marketscreener.com
UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS - Quantisnow
Bio-Techne Stock Set to Benefit From Expansion of RNAscope Menu - MSN
Bio-Techne Sets Date for Q3 2025 Financial Results: Key Details for Investors - Stock Titan
Strength Seen in Bio-Techne (TECH): Can Its 10.8% Jump Turn into More Strength? - Yahoo Finance
Bio-Techne (TECH) Faces Downgrade Amid NIH Funding Concerns - GuruFocus
Forecasting The Future: 6 Analyst Projections For Bio-Techne - Benzinga
This PTC Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
Bio-Techne stock downgraded at KeyBanc (TECH:NASDAQ) - Seeking Alpha
KeyBanc Downgrades Bio-Techne to Sector Weight From Overweight - MarketScreener
KeyBanc cuts Bio-Techne stock rating on funding concerns By Investing.com - Investing.com India
KeyBanc cuts Bio-Techne stock rating on funding concerns - Investing.com
Trading (TECH) With Integrated Risk Controls - news.stocktradersdaily.com
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.
Spatial Genomics and Transcriptomics Industry Analysis Report 2025, Featuring Detailed Profiles of Leading Players10x Genomics, Bruker Corp., Akoya Biosciences, and Bio-Techne Among OthersResearchAndMarkets.com - Bluefield Daily Telegraph
Techne Corp stock hits 52-week low at $56.58 amid market shifts - Investing.com
Bio-Techne Expands Collaboration With Leica To Enhance Spatial Multiomics Research Capabilities - Nasdaq
Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument - PR Newswire
Evercore ISI Adjusts Bio-Techne Price Target to $70 From $75, Maintains Outperform Rating - marketscreener.com
Is Bio-Techne Corporation Stock Underperforming the S&P 500? - Nasdaq
Is Bio-Techne Corporation Stock Underperforming The S&P 500? - Barchart.com
Bio-Techne Opens New Customer Experience Centre in Germany - Nasdaq
3 Reasons to Avoid TECH and 1 Stock to Buy Instead - Yahoo Finance
11 Best Gene Therapy Stocks to Buy According to Analysts - Insider Monkey
Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch - Yahoo Finance
Bio-Techne to Open New Customer Facility in Germany - Marketscreener.com
Bio-Techne's New Tech Hub Targets Major European Life Sciences Growth - Stock Titan
Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting - Quantisnow
Game-Changing Cancer Detection Technology: RNAscope Shows Superior Results in Multiple Tumors - Stock Titan
Bio-Techne Earnings Preview: What to Expect - MSN
Evercore ISI Group Initiates Coverage of Bio-Techne (TECH) with Outperform Recommendation - MSN
Evercore ISI sets Bio-Techne stock Outperform with $75 target By Investing.com - Investing.com South Africa
6 Analysts Assess Bio-Techne: What You Need To Know - Benzinga
Evercore ISI sets Bio-Techne stock Outperform with $75 target - Investing.com
Bio-Techne: A Premium Growth Asset with Strong Market Position and Promising Future - TipRanks
Bio-Techne (NASDAQ:TECH) shareholders have earned a 8.3% CAGR over the last five years - Yahoo Finance
Bio-Techne (NASDAQ:TECH) Downgraded by StockNews.com to "Hold" - MarketBeat
Bio-Techne Co. (NASDAQ:TECH) Receives $82.14 Consensus Price Target from Analysts - Defense World
Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - GlobeNewswire Inc.
Bio Techne at Barclays Conference: Strategic Growth Amid Market Challenges - Investing.com
TECH Stock Might Rise Following the Leo Shipping Announcement - Nasdaq
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Bio-Techne at Leerink’s Global Healthcare Conference: Strategic Growth Amid Challenges - Investing.com India
Techne Corp stock hits 52-week low at $58.94 amid market shifts - Investing.com India
Techne Corp stock hits 52-week low at $58.94 amid market shifts By Investing.com - Investing.com South Africa
GC Wealth Management RIA LLC Takes $805,000 Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Corp (TECH) Q1 FY2025 Earnings: Revenue Surpasses Est - GuruFocus.com
Bio-Techne Begins Shipping LeoA Next Generation High-Throughput Simple Western System - Quantisnow
Bio-Techne launches high-throughput Leo System - Investing.com
大文字化:
|
ボリューム (24 時間):